Jiangsu Senxuan Pharmaceutical and Chemical Co., Ltd. announced that it expects to receive CNY 19.8 million in funding from Nantong Jinghua Pharmaceutical Co., Ltd.
January 02, 2017
Share
Jiangsu Senxuan Pharmaceutical and Chemical Co., Ltd. announced a private placement of 3,300,000 shares at CNY 6 per share for gross proceeds of CNY 19,800,000 on January 3, 2017. The transaction will include participation from returning investor Nantong Jinghua Pharmaceutical Co., Ltd. (SZSE:002349) for CNY 10,098,000. The transaction was approved at the 6th extraordinary shareholders’ meeting of 2016 of Nantong Jinghua Pharmaceutical Co., Ltd.
On the same date, the company received CNY 10,098,000 in its first tranche from Nantong Jinghua Pharmaceutical Co., Ltd.
JINGHUA PHARMACEUTICAL GROUP CO., LTD., formerly NANTONG JINGHUA PHARMACEUTICAL CO., LTD., is a China-based company, principally engaged in the research and development, production and distribution of Chinese patent drugs, pharm ingredients and intermediates and chemical intermediates. The Company is also engaged in the provision of traditional Chinese medicinal materials and Chinese herbal pieces, among others. The Company primarily provides tablets, capsules, pills, granules, injections, powder, syrup, healthcare products, beverages and chemical intermediates, among others. The Company offers Chinese patent medicines, such as Wangshi Baochiwan pills and Jidesheng tablets. Its bulk drugs include phenobarbitone and fluorouracil. The Company distributes its products in domestic and overseas markets.
Jiangsu Senxuan Pharmaceutical and Chemical Co., Ltd. announced that it expects to receive CNY 19.8 million in funding from Nantong Jinghua Pharmaceutical Co., Ltd.
JINGHUA PHARMACEUTICAL GROUP CO., LTD. 
